Yahoo Web Search

Search results

    • TIME100 Health: David Ricks

      TIME100 Health: David Ricks

      Time via Yahoo Finance· 1 hour ago

      The U.S. Food and Drug Administration (FDA) approved Lilly’s tirzepatide, marketed as Mounjaro for diabetes, in 2022, and Zepbound for obesity in 2023,...